Cargando…
A case of malignant hypertension as a presentation of atypical hemolytic uremic syndrome
Introduction: Malignant hypertension (mHTN) damages multiple target organs, including the kidneys. mHTN has been regarded as one of the causes of secondary thrombotic microangiopathy (TMA); however, a high prevalence of complement gene abnormalities was recently reported in cohorts of mHTN. Case rep...
Autores principales: | Omiya, Chiaki, Koga, Kenichi, Nishioka, Keisuke, Sugawara, Akira, Sugawara, Yuka, Yoshida, Yoko, Ikeda, Yoichiro, Yahata, Kensei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152566/ https://www.ncbi.nlm.nih.gov/pubmed/37143613 http://dx.doi.org/10.5414/CNCS110901 |
Ejemplares similares
-
Pathogenesis of Atypical Hemolytic Uremic Syndrome
por: Yoshida, Yoko, et al.
Publicado: (2019) -
CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome
por: Sugawara, Yuka, et al.
Publicado: (2023) -
Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase
por: Sakurai, Satoko, et al.
Publicado: (2020) -
Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome
por: Raghunathan, V., et al.
Publicado: (2017) -
Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)